Global Insulin Pumps

Insulin Pumps Comprehensive Study by Type (Pumps, -Tethered Pumps, -Patch Pumps, -Others, Consumables), Distribution Channel (Online, Offline, -Hospital Pharmacy, -Retail Pharmacy, -Others), Disease Indication (Type 1 Diabetes, Type 2 Diabetes) Players and Region - Global Market Outlook to 2028

Insulin Pumps Market by XX Submarkets | Forecast Years 2023-2028  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Global Insulin Pumps Market Overview:
Insulin pumps are compact, computer-controlled devices designed and programmed to administer precise insulin doses to individuals with diabetes. The market for these pumps has expanded in recent years to address the growing demand for portable insulin delivery solutions among the diabetic population. A key driver of market growth is the escalating prevalence of diabetes, particularly type 1 diabetes, worldwide. Furthermore, the development of cutting-edge pumps equipped with smart technologies, such as Artificial Intelligence (AI) and Machine Learning (ML), by leading medical device manufacturers has also emerged as a crucial factor propelling market growth.

AttributesDetails
Study Period2018-2028
Base Year2022
Forecast Period2023-2028
Historical Period2018-2022
UnitValue (USD Million)
Customization ScopeAvail customization with purchase of this report. Add or modify country, region & or narrow down segments in the final scope subject to feasibility

Competitive Landscape:

Some of the key players profiled in the report are Medtronic (Ireland), Tandem Diabetes Care (United States), Insulet Corporation (United States), F. Hoffmann-La Roche Ltd (Switzerland), Animas Corporation (United States), SOOIL Development (South Korea), New Genix (Spain), Debiotech (Denmark), Asante Solutions (United States) and Apex Medical (United States). Additionally, following companies can also be profiled that are part of our coverage like Twobiens (China), Fornia (Taiwan), Shinmyung Mediyes (South Korea) and Phray (Thailand). Considering Market by Distribution Channel, the sub-segment i.e. Online will boost the Insulin Pumps market. Considering Market by Disease Indication, the sub-segment i.e. Type 1 Diabetes will boost the Insulin Pumps market.

What Can be Explored with the Insulin Pumps Market Study
 Gain Market Understanding
 Identify Growth Opportunities
 Analyze and Measure the Global Insulin Pumps Market by Identifying Investment across various Industry Verticals
 Understand the Trends that will drive Future Changes in Insulin Pumps
 Understand the Competitive Scenario
- Track Right Markets
- Identify the Right Verticals

Research Methodology:
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Insulin Pumps market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Insulin Pumps market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.

Report Objectives / Segmentation Covered

By Type
  • Pumps
  • -Tethered Pumps
  • -Patch Pumps
  • -Others
  • Consumables
By Distribution Channel
  • Online
  • Offline
  • -Hospital Pharmacy
  • -Retail Pharmacy
  • -Others

By Disease Indication
  • Type 1 Diabetes
  • Type 2 Diabetes

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Factor Analysis
    • 3.1. Porters Five Forces
    • 3.2. Supply/Value Chain
    • 3.3. PESTEL analysis
    • 3.4. Market Entropy
    • 3.5. Patent/Trademark Analysis
  • 4. Global Insulin Pumps, by Type, Distribution Channel, Disease Indication and Region (value) (2017-2022)
    • 4.1. Introduction
    • 4.2. Global Insulin Pumps (Value)
      • 4.2.1. Global Insulin Pumps by: Type (Value)
        • 4.2.1.1. Pumps
        • 4.2.1.2. -Tethered Pumps
        • 4.2.1.3. -Patch Pumps
        • 4.2.1.4. -Others
        • 4.2.1.5. Consumables
      • 4.2.2. Global Insulin Pumps by: Distribution Channel (Value)
        • 4.2.2.1. Online
        • 4.2.2.2. Offline
        • 4.2.2.3. -Hospital Pharmacy
        • 4.2.2.4. -Retail Pharmacy
        • 4.2.2.5. -Others
      • 4.2.3. Global Insulin Pumps by: Disease Indication (Value)
        • 4.2.3.1. Type 1 Diabetes
        • 4.2.3.2. Type 2 Diabetes
      • 4.2.4. Global Insulin Pumps Region
        • 4.2.4.1. South America
          • 4.2.4.1.1. Brazil
          • 4.2.4.1.2. Argentina
          • 4.2.4.1.3. Rest of South America
        • 4.2.4.2. Asia Pacific
          • 4.2.4.2.1. China
          • 4.2.4.2.2. Japan
          • 4.2.4.2.3. India
          • 4.2.4.2.4. South Korea
          • 4.2.4.2.5. Taiwan
          • 4.2.4.2.6. Australia
          • 4.2.4.2.7. Rest of Asia-Pacific
        • 4.2.4.3. Europe
          • 4.2.4.3.1. Germany
          • 4.2.4.3.2. France
          • 4.2.4.3.3. Italy
          • 4.2.4.3.4. United Kingdom
          • 4.2.4.3.5. Netherlands
          • 4.2.4.3.6. Rest of Europe
        • 4.2.4.4. MEA
          • 4.2.4.4.1. Middle East
          • 4.2.4.4.2. Africa
        • 4.2.4.5. North America
          • 4.2.4.5.1. United States
          • 4.2.4.5.2. Canada
          • 4.2.4.5.3. Mexico
  • 5. Insulin Pumps: Manufacturers/Players Analysis
    • 5.1. Competitive Landscape
      • 5.1.1. Market Share Analysis
        • 5.1.1.1. Top 3
        • 5.1.1.2. Top 5
    • 5.2. Peer Group Analysis (2022)
    • 5.3. BCG Matrix
    • 5.4. Company Profile
      • 5.4.1. Medtronic (Ireland)
        • 5.4.1.1. Business Overview
        • 5.4.1.2. Products/Services Offerings
        • 5.4.1.3. Financial Analysis
        • 5.4.1.4. SWOT Analysis
      • 5.4.2. Tandem Diabetes Care (United States)
        • 5.4.2.1. Business Overview
        • 5.4.2.2. Products/Services Offerings
        • 5.4.2.3. Financial Analysis
        • 5.4.2.4. SWOT Analysis
      • 5.4.3. Insulet Corporation (United States)
        • 5.4.3.1. Business Overview
        • 5.4.3.2. Products/Services Offerings
        • 5.4.3.3. Financial Analysis
        • 5.4.3.4. SWOT Analysis
      • 5.4.4. F. Hoffmann-La Roche Ltd (Switzerland)
        • 5.4.4.1. Business Overview
        • 5.4.4.2. Products/Services Offerings
        • 5.4.4.3. Financial Analysis
        • 5.4.4.4. SWOT Analysis
      • 5.4.5. Animas Corporation (United States)
        • 5.4.5.1. Business Overview
        • 5.4.5.2. Products/Services Offerings
        • 5.4.5.3. Financial Analysis
        • 5.4.5.4. SWOT Analysis
      • 5.4.6. SOOIL Development (South Korea)
        • 5.4.6.1. Business Overview
        • 5.4.6.2. Products/Services Offerings
        • 5.4.6.3. Financial Analysis
        • 5.4.6.4. SWOT Analysis
      • 5.4.7. New Genix (Spain)
        • 5.4.7.1. Business Overview
        • 5.4.7.2. Products/Services Offerings
        • 5.4.7.3. Financial Analysis
        • 5.4.7.4. SWOT Analysis
      • 5.4.8. Debiotech (Denmark)
        • 5.4.8.1. Business Overview
        • 5.4.8.2. Products/Services Offerings
        • 5.4.8.3. Financial Analysis
        • 5.4.8.4. SWOT Analysis
      • 5.4.9. Asante Solutions (United States)
        • 5.4.9.1. Business Overview
        • 5.4.9.2. Products/Services Offerings
        • 5.4.9.3. Financial Analysis
        • 5.4.9.4. SWOT Analysis
      • 5.4.10. Apex Medical (United States)
        • 5.4.10.1. Business Overview
        • 5.4.10.2. Products/Services Offerings
        • 5.4.10.3. Financial Analysis
        • 5.4.10.4. SWOT Analysis
  • 6. Global Insulin Pumps Sale, by Type, Distribution Channel, Disease Indication and Region (value) (2023-2028)
    • 6.1. Introduction
    • 6.2. Global Insulin Pumps (Value)
      • 6.2.1. Global Insulin Pumps by: Type (Value)
        • 6.2.1.1. Pumps
        • 6.2.1.2. -Tethered Pumps
        • 6.2.1.3. -Patch Pumps
        • 6.2.1.4. -Others
        • 6.2.1.5. Consumables
      • 6.2.2. Global Insulin Pumps by: Distribution Channel (Value)
        • 6.2.2.1. Online
        • 6.2.2.2. Offline
        • 6.2.2.3. -Hospital Pharmacy
        • 6.2.2.4. -Retail Pharmacy
        • 6.2.2.5. -Others
      • 6.2.3. Global Insulin Pumps by: Disease Indication (Value)
        • 6.2.3.1. Type 1 Diabetes
        • 6.2.3.2. Type 2 Diabetes
      • 6.2.4. Global Insulin Pumps Region
        • 6.2.4.1. South America
          • 6.2.4.1.1. Brazil
          • 6.2.4.1.2. Argentina
          • 6.2.4.1.3. Rest of South America
        • 6.2.4.2. Asia Pacific
          • 6.2.4.2.1. China
          • 6.2.4.2.2. Japan
          • 6.2.4.2.3. India
          • 6.2.4.2.4. South Korea
          • 6.2.4.2.5. Taiwan
          • 6.2.4.2.6. Australia
          • 6.2.4.2.7. Rest of Asia-Pacific
        • 6.2.4.3. Europe
          • 6.2.4.3.1. Germany
          • 6.2.4.3.2. France
          • 6.2.4.3.3. Italy
          • 6.2.4.3.4. United Kingdom
          • 6.2.4.3.5. Netherlands
          • 6.2.4.3.6. Rest of Europe
        • 6.2.4.4. MEA
          • 6.2.4.4.1. Middle East
          • 6.2.4.4.2. Africa
        • 6.2.4.5. North America
          • 6.2.4.5.1. United States
          • 6.2.4.5.2. Canada
          • 6.2.4.5.3. Mexico
  • 7. Appendix
    • 7.1. Acronyms
  • 8. Methodology and Data Source
    • 8.1. Methodology/Research Approach
      • 8.1.1. Research Programs/Design
      • 8.1.2. Market Size Estimation
      • 8.1.3. Market Breakdown and Data Triangulation
    • 8.2. Data Source
      • 8.2.1. Secondary Sources
      • 8.2.2. Primary Sources
    • 8.3. Disclaimer
List of Tables
  • Table 1. Insulin Pumps: by Type(USD Million)
  • Table 2. Insulin Pumps Pumps , by Region USD Million (2017-2022)
  • Table 3. Insulin Pumps -Tethered Pumps , by Region USD Million (2017-2022)
  • Table 4. Insulin Pumps -Patch Pumps , by Region USD Million (2017-2022)
  • Table 5. Insulin Pumps -Others , by Region USD Million (2017-2022)
  • Table 6. Insulin Pumps Consumables , by Region USD Million (2017-2022)
  • Table 7. Insulin Pumps: by Distribution Channel(USD Million)
  • Table 8. Insulin Pumps Online , by Region USD Million (2017-2022)
  • Table 9. Insulin Pumps Offline , by Region USD Million (2017-2022)
  • Table 10. Insulin Pumps -Hospital Pharmacy , by Region USD Million (2017-2022)
  • Table 11. Insulin Pumps -Retail Pharmacy , by Region USD Million (2017-2022)
  • Table 12. Insulin Pumps -Others , by Region USD Million (2017-2022)
  • Table 13. Insulin Pumps: by Disease Indication(USD Million)
  • Table 14. Insulin Pumps Type 1 Diabetes , by Region USD Million (2017-2022)
  • Table 15. Insulin Pumps Type 2 Diabetes , by Region USD Million (2017-2022)
  • Table 16. South America Insulin Pumps, by Country USD Million (2017-2022)
  • Table 17. South America Insulin Pumps, by Type USD Million (2017-2022)
  • Table 18. South America Insulin Pumps, by Distribution Channel USD Million (2017-2022)
  • Table 19. South America Insulin Pumps, by Disease Indication USD Million (2017-2022)
  • Table 20. Brazil Insulin Pumps, by Type USD Million (2017-2022)
  • Table 21. Brazil Insulin Pumps, by Distribution Channel USD Million (2017-2022)
  • Table 22. Brazil Insulin Pumps, by Disease Indication USD Million (2017-2022)
  • Table 23. Argentina Insulin Pumps, by Type USD Million (2017-2022)
  • Table 24. Argentina Insulin Pumps, by Distribution Channel USD Million (2017-2022)
  • Table 25. Argentina Insulin Pumps, by Disease Indication USD Million (2017-2022)
  • Table 26. Rest of South America Insulin Pumps, by Type USD Million (2017-2022)
  • Table 27. Rest of South America Insulin Pumps, by Distribution Channel USD Million (2017-2022)
  • Table 28. Rest of South America Insulin Pumps, by Disease Indication USD Million (2017-2022)
  • Table 29. Asia Pacific Insulin Pumps, by Country USD Million (2017-2022)
  • Table 30. Asia Pacific Insulin Pumps, by Type USD Million (2017-2022)
  • Table 31. Asia Pacific Insulin Pumps, by Distribution Channel USD Million (2017-2022)
  • Table 32. Asia Pacific Insulin Pumps, by Disease Indication USD Million (2017-2022)
  • Table 33. China Insulin Pumps, by Type USD Million (2017-2022)
  • Table 34. China Insulin Pumps, by Distribution Channel USD Million (2017-2022)
  • Table 35. China Insulin Pumps, by Disease Indication USD Million (2017-2022)
  • Table 36. Japan Insulin Pumps, by Type USD Million (2017-2022)
  • Table 37. Japan Insulin Pumps, by Distribution Channel USD Million (2017-2022)
  • Table 38. Japan Insulin Pumps, by Disease Indication USD Million (2017-2022)
  • Table 39. India Insulin Pumps, by Type USD Million (2017-2022)
  • Table 40. India Insulin Pumps, by Distribution Channel USD Million (2017-2022)
  • Table 41. India Insulin Pumps, by Disease Indication USD Million (2017-2022)
  • Table 42. South Korea Insulin Pumps, by Type USD Million (2017-2022)
  • Table 43. South Korea Insulin Pumps, by Distribution Channel USD Million (2017-2022)
  • Table 44. South Korea Insulin Pumps, by Disease Indication USD Million (2017-2022)
  • Table 45. Taiwan Insulin Pumps, by Type USD Million (2017-2022)
  • Table 46. Taiwan Insulin Pumps, by Distribution Channel USD Million (2017-2022)
  • Table 47. Taiwan Insulin Pumps, by Disease Indication USD Million (2017-2022)
  • Table 48. Australia Insulin Pumps, by Type USD Million (2017-2022)
  • Table 49. Australia Insulin Pumps, by Distribution Channel USD Million (2017-2022)
  • Table 50. Australia Insulin Pumps, by Disease Indication USD Million (2017-2022)
  • Table 51. Rest of Asia-Pacific Insulin Pumps, by Type USD Million (2017-2022)
  • Table 52. Rest of Asia-Pacific Insulin Pumps, by Distribution Channel USD Million (2017-2022)
  • Table 53. Rest of Asia-Pacific Insulin Pumps, by Disease Indication USD Million (2017-2022)
  • Table 54. Europe Insulin Pumps, by Country USD Million (2017-2022)
  • Table 55. Europe Insulin Pumps, by Type USD Million (2017-2022)
  • Table 56. Europe Insulin Pumps, by Distribution Channel USD Million (2017-2022)
  • Table 57. Europe Insulin Pumps, by Disease Indication USD Million (2017-2022)
  • Table 58. Germany Insulin Pumps, by Type USD Million (2017-2022)
  • Table 59. Germany Insulin Pumps, by Distribution Channel USD Million (2017-2022)
  • Table 60. Germany Insulin Pumps, by Disease Indication USD Million (2017-2022)
  • Table 61. France Insulin Pumps, by Type USD Million (2017-2022)
  • Table 62. France Insulin Pumps, by Distribution Channel USD Million (2017-2022)
  • Table 63. France Insulin Pumps, by Disease Indication USD Million (2017-2022)
  • Table 64. Italy Insulin Pumps, by Type USD Million (2017-2022)
  • Table 65. Italy Insulin Pumps, by Distribution Channel USD Million (2017-2022)
  • Table 66. Italy Insulin Pumps, by Disease Indication USD Million (2017-2022)
  • Table 67. United Kingdom Insulin Pumps, by Type USD Million (2017-2022)
  • Table 68. United Kingdom Insulin Pumps, by Distribution Channel USD Million (2017-2022)
  • Table 69. United Kingdom Insulin Pumps, by Disease Indication USD Million (2017-2022)
  • Table 70. Netherlands Insulin Pumps, by Type USD Million (2017-2022)
  • Table 71. Netherlands Insulin Pumps, by Distribution Channel USD Million (2017-2022)
  • Table 72. Netherlands Insulin Pumps, by Disease Indication USD Million (2017-2022)
  • Table 73. Rest of Europe Insulin Pumps, by Type USD Million (2017-2022)
  • Table 74. Rest of Europe Insulin Pumps, by Distribution Channel USD Million (2017-2022)
  • Table 75. Rest of Europe Insulin Pumps, by Disease Indication USD Million (2017-2022)
  • Table 76. MEA Insulin Pumps, by Country USD Million (2017-2022)
  • Table 77. MEA Insulin Pumps, by Type USD Million (2017-2022)
  • Table 78. MEA Insulin Pumps, by Distribution Channel USD Million (2017-2022)
  • Table 79. MEA Insulin Pumps, by Disease Indication USD Million (2017-2022)
  • Table 80. Middle East Insulin Pumps, by Type USD Million (2017-2022)
  • Table 81. Middle East Insulin Pumps, by Distribution Channel USD Million (2017-2022)
  • Table 82. Middle East Insulin Pumps, by Disease Indication USD Million (2017-2022)
  • Table 83. Africa Insulin Pumps, by Type USD Million (2017-2022)
  • Table 84. Africa Insulin Pumps, by Distribution Channel USD Million (2017-2022)
  • Table 85. Africa Insulin Pumps, by Disease Indication USD Million (2017-2022)
  • Table 86. North America Insulin Pumps, by Country USD Million (2017-2022)
  • Table 87. North America Insulin Pumps, by Type USD Million (2017-2022)
  • Table 88. North America Insulin Pumps, by Distribution Channel USD Million (2017-2022)
  • Table 89. North America Insulin Pumps, by Disease Indication USD Million (2017-2022)
  • Table 90. United States Insulin Pumps, by Type USD Million (2017-2022)
  • Table 91. United States Insulin Pumps, by Distribution Channel USD Million (2017-2022)
  • Table 92. United States Insulin Pumps, by Disease Indication USD Million (2017-2022)
  • Table 93. Canada Insulin Pumps, by Type USD Million (2017-2022)
  • Table 94. Canada Insulin Pumps, by Distribution Channel USD Million (2017-2022)
  • Table 95. Canada Insulin Pumps, by Disease Indication USD Million (2017-2022)
  • Table 96. Mexico Insulin Pumps, by Type USD Million (2017-2022)
  • Table 97. Mexico Insulin Pumps, by Distribution Channel USD Million (2017-2022)
  • Table 98. Mexico Insulin Pumps, by Disease Indication USD Million (2017-2022)
  • Table 99. Company Basic Information, Sales Area and Its Competitors
  • Table 100. Company Basic Information, Sales Area and Its Competitors
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Company Basic Information, Sales Area and Its Competitors
  • Table 107. Company Basic Information, Sales Area and Its Competitors
  • Table 108. Company Basic Information, Sales Area and Its Competitors
  • Table 109. Insulin Pumps: by Type(USD Million)
  • Table 110. Insulin Pumps Pumps , by Region USD Million (2023-2028)
  • Table 111. Insulin Pumps -Tethered Pumps , by Region USD Million (2023-2028)
  • Table 112. Insulin Pumps -Patch Pumps , by Region USD Million (2023-2028)
  • Table 113. Insulin Pumps -Others , by Region USD Million (2023-2028)
  • Table 114. Insulin Pumps Consumables , by Region USD Million (2023-2028)
  • Table 115. Insulin Pumps: by Distribution Channel(USD Million)
  • Table 116. Insulin Pumps Online , by Region USD Million (2023-2028)
  • Table 117. Insulin Pumps Offline , by Region USD Million (2023-2028)
  • Table 118. Insulin Pumps -Hospital Pharmacy , by Region USD Million (2023-2028)
  • Table 119. Insulin Pumps -Retail Pharmacy , by Region USD Million (2023-2028)
  • Table 120. Insulin Pumps -Others , by Region USD Million (2023-2028)
  • Table 121. Insulin Pumps: by Disease Indication(USD Million)
  • Table 122. Insulin Pumps Type 1 Diabetes , by Region USD Million (2023-2028)
  • Table 123. Insulin Pumps Type 2 Diabetes , by Region USD Million (2023-2028)
  • Table 124. South America Insulin Pumps, by Country USD Million (2023-2028)
  • Table 125. South America Insulin Pumps, by Type USD Million (2023-2028)
  • Table 126. South America Insulin Pumps, by Distribution Channel USD Million (2023-2028)
  • Table 127. South America Insulin Pumps, by Disease Indication USD Million (2023-2028)
  • Table 128. Brazil Insulin Pumps, by Type USD Million (2023-2028)
  • Table 129. Brazil Insulin Pumps, by Distribution Channel USD Million (2023-2028)
  • Table 130. Brazil Insulin Pumps, by Disease Indication USD Million (2023-2028)
  • Table 131. Argentina Insulin Pumps, by Type USD Million (2023-2028)
  • Table 132. Argentina Insulin Pumps, by Distribution Channel USD Million (2023-2028)
  • Table 133. Argentina Insulin Pumps, by Disease Indication USD Million (2023-2028)
  • Table 134. Rest of South America Insulin Pumps, by Type USD Million (2023-2028)
  • Table 135. Rest of South America Insulin Pumps, by Distribution Channel USD Million (2023-2028)
  • Table 136. Rest of South America Insulin Pumps, by Disease Indication USD Million (2023-2028)
  • Table 137. Asia Pacific Insulin Pumps, by Country USD Million (2023-2028)
  • Table 138. Asia Pacific Insulin Pumps, by Type USD Million (2023-2028)
  • Table 139. Asia Pacific Insulin Pumps, by Distribution Channel USD Million (2023-2028)
  • Table 140. Asia Pacific Insulin Pumps, by Disease Indication USD Million (2023-2028)
  • Table 141. China Insulin Pumps, by Type USD Million (2023-2028)
  • Table 142. China Insulin Pumps, by Distribution Channel USD Million (2023-2028)
  • Table 143. China Insulin Pumps, by Disease Indication USD Million (2023-2028)
  • Table 144. Japan Insulin Pumps, by Type USD Million (2023-2028)
  • Table 145. Japan Insulin Pumps, by Distribution Channel USD Million (2023-2028)
  • Table 146. Japan Insulin Pumps, by Disease Indication USD Million (2023-2028)
  • Table 147. India Insulin Pumps, by Type USD Million (2023-2028)
  • Table 148. India Insulin Pumps, by Distribution Channel USD Million (2023-2028)
  • Table 149. India Insulin Pumps, by Disease Indication USD Million (2023-2028)
  • Table 150. South Korea Insulin Pumps, by Type USD Million (2023-2028)
  • Table 151. South Korea Insulin Pumps, by Distribution Channel USD Million (2023-2028)
  • Table 152. South Korea Insulin Pumps, by Disease Indication USD Million (2023-2028)
  • Table 153. Taiwan Insulin Pumps, by Type USD Million (2023-2028)
  • Table 154. Taiwan Insulin Pumps, by Distribution Channel USD Million (2023-2028)
  • Table 155. Taiwan Insulin Pumps, by Disease Indication USD Million (2023-2028)
  • Table 156. Australia Insulin Pumps, by Type USD Million (2023-2028)
  • Table 157. Australia Insulin Pumps, by Distribution Channel USD Million (2023-2028)
  • Table 158. Australia Insulin Pumps, by Disease Indication USD Million (2023-2028)
  • Table 159. Rest of Asia-Pacific Insulin Pumps, by Type USD Million (2023-2028)
  • Table 160. Rest of Asia-Pacific Insulin Pumps, by Distribution Channel USD Million (2023-2028)
  • Table 161. Rest of Asia-Pacific Insulin Pumps, by Disease Indication USD Million (2023-2028)
  • Table 162. Europe Insulin Pumps, by Country USD Million (2023-2028)
  • Table 163. Europe Insulin Pumps, by Type USD Million (2023-2028)
  • Table 164. Europe Insulin Pumps, by Distribution Channel USD Million (2023-2028)
  • Table 165. Europe Insulin Pumps, by Disease Indication USD Million (2023-2028)
  • Table 166. Germany Insulin Pumps, by Type USD Million (2023-2028)
  • Table 167. Germany Insulin Pumps, by Distribution Channel USD Million (2023-2028)
  • Table 168. Germany Insulin Pumps, by Disease Indication USD Million (2023-2028)
  • Table 169. France Insulin Pumps, by Type USD Million (2023-2028)
  • Table 170. France Insulin Pumps, by Distribution Channel USD Million (2023-2028)
  • Table 171. France Insulin Pumps, by Disease Indication USD Million (2023-2028)
  • Table 172. Italy Insulin Pumps, by Type USD Million (2023-2028)
  • Table 173. Italy Insulin Pumps, by Distribution Channel USD Million (2023-2028)
  • Table 174. Italy Insulin Pumps, by Disease Indication USD Million (2023-2028)
  • Table 175. United Kingdom Insulin Pumps, by Type USD Million (2023-2028)
  • Table 176. United Kingdom Insulin Pumps, by Distribution Channel USD Million (2023-2028)
  • Table 177. United Kingdom Insulin Pumps, by Disease Indication USD Million (2023-2028)
  • Table 178. Netherlands Insulin Pumps, by Type USD Million (2023-2028)
  • Table 179. Netherlands Insulin Pumps, by Distribution Channel USD Million (2023-2028)
  • Table 180. Netherlands Insulin Pumps, by Disease Indication USD Million (2023-2028)
  • Table 181. Rest of Europe Insulin Pumps, by Type USD Million (2023-2028)
  • Table 182. Rest of Europe Insulin Pumps, by Distribution Channel USD Million (2023-2028)
  • Table 183. Rest of Europe Insulin Pumps, by Disease Indication USD Million (2023-2028)
  • Table 184. MEA Insulin Pumps, by Country USD Million (2023-2028)
  • Table 185. MEA Insulin Pumps, by Type USD Million (2023-2028)
  • Table 186. MEA Insulin Pumps, by Distribution Channel USD Million (2023-2028)
  • Table 187. MEA Insulin Pumps, by Disease Indication USD Million (2023-2028)
  • Table 188. Middle East Insulin Pumps, by Type USD Million (2023-2028)
  • Table 189. Middle East Insulin Pumps, by Distribution Channel USD Million (2023-2028)
  • Table 190. Middle East Insulin Pumps, by Disease Indication USD Million (2023-2028)
  • Table 191. Africa Insulin Pumps, by Type USD Million (2023-2028)
  • Table 192. Africa Insulin Pumps, by Distribution Channel USD Million (2023-2028)
  • Table 193. Africa Insulin Pumps, by Disease Indication USD Million (2023-2028)
  • Table 194. North America Insulin Pumps, by Country USD Million (2023-2028)
  • Table 195. North America Insulin Pumps, by Type USD Million (2023-2028)
  • Table 196. North America Insulin Pumps, by Distribution Channel USD Million (2023-2028)
  • Table 197. North America Insulin Pumps, by Disease Indication USD Million (2023-2028)
  • Table 198. United States Insulin Pumps, by Type USD Million (2023-2028)
  • Table 199. United States Insulin Pumps, by Distribution Channel USD Million (2023-2028)
  • Table 200. United States Insulin Pumps, by Disease Indication USD Million (2023-2028)
  • Table 201. Canada Insulin Pumps, by Type USD Million (2023-2028)
  • Table 202. Canada Insulin Pumps, by Distribution Channel USD Million (2023-2028)
  • Table 203. Canada Insulin Pumps, by Disease Indication USD Million (2023-2028)
  • Table 204. Mexico Insulin Pumps, by Type USD Million (2023-2028)
  • Table 205. Mexico Insulin Pumps, by Distribution Channel USD Million (2023-2028)
  • Table 206. Mexico Insulin Pumps, by Disease Indication USD Million (2023-2028)
  • Table 207. Research Programs/Design for This Report
  • Table 208. Key Data Information from Secondary Sources
  • Table 209. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Insulin Pumps: by Type USD Million (2017-2022)
  • Figure 5. Global Insulin Pumps: by Distribution Channel USD Million (2017-2022)
  • Figure 6. Global Insulin Pumps: by Disease Indication USD Million (2017-2022)
  • Figure 7. South America Insulin Pumps Share (%), by Country
  • Figure 8. Asia Pacific Insulin Pumps Share (%), by Country
  • Figure 9. Europe Insulin Pumps Share (%), by Country
  • Figure 10. MEA Insulin Pumps Share (%), by Country
  • Figure 11. North America Insulin Pumps Share (%), by Country
  • Figure 12. Global Insulin Pumps share by Players 2022 (%)
  • Figure 13. Global Insulin Pumps share by Players (Top 3) 2022(%)
  • Figure 14. Global Insulin Pumps share by Players (Top 5) 2022(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. Medtronic (Ireland) Revenue, Net Income and Gross profit
  • Figure 17. Medtronic (Ireland) Revenue: by Geography 2022
  • Figure 18. Tandem Diabetes Care (United States) Revenue, Net Income and Gross profit
  • Figure 19. Tandem Diabetes Care (United States) Revenue: by Geography 2022
  • Figure 20. Insulet Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 21. Insulet Corporation (United States) Revenue: by Geography 2022
  • Figure 22. F. Hoffmann-La Roche Ltd (Switzerland) Revenue, Net Income and Gross profit
  • Figure 23. F. Hoffmann-La Roche Ltd (Switzerland) Revenue: by Geography 2022
  • Figure 24. Animas Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 25. Animas Corporation (United States) Revenue: by Geography 2022
  • Figure 26. SOOIL Development (South Korea) Revenue, Net Income and Gross profit
  • Figure 27. SOOIL Development (South Korea) Revenue: by Geography 2022
  • Figure 28. New Genix (Spain) Revenue, Net Income and Gross profit
  • Figure 29. New Genix (Spain) Revenue: by Geography 2022
  • Figure 30. Debiotech (Denmark) Revenue, Net Income and Gross profit
  • Figure 31. Debiotech (Denmark) Revenue: by Geography 2022
  • Figure 32. Asante Solutions (United States) Revenue, Net Income and Gross profit
  • Figure 33. Asante Solutions (United States) Revenue: by Geography 2022
  • Figure 34. Apex Medical (United States) Revenue, Net Income and Gross profit
  • Figure 35. Apex Medical (United States) Revenue: by Geography 2022
  • Figure 36. Global Insulin Pumps: by Type USD Million (2023-2028)
  • Figure 37. Global Insulin Pumps: by Distribution Channel USD Million (2023-2028)
  • Figure 38. Global Insulin Pumps: by Disease Indication USD Million (2023-2028)
  • Figure 39. South America Insulin Pumps Share (%), by Country
  • Figure 40. Asia Pacific Insulin Pumps Share (%), by Country
  • Figure 41. Europe Insulin Pumps Share (%), by Country
  • Figure 42. MEA Insulin Pumps Share (%), by Country
  • Figure 43. North America Insulin Pumps Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Medtronic (Ireland)
  • Tandem Diabetes Care (United States)
  • Insulet Corporation (United States)
  • F. Hoffmann-La Roche Ltd (Switzerland)
  • Animas Corporation (United States)
  • SOOIL Development (South Korea)
  • New Genix (Spain)
  • Debiotech (Denmark)
  • Asante Solutions (United States)
  • Apex Medical (United States)
Additional players considered in the study are as follows:
Twobiens (China) , Fornia (Taiwan) , Shinmyung Mediyes (South Korea) , Phray (Thailand)
Select User Access Type

Key Highlights of Report


Nov 2023 245 Pages 63 Tables Base Year: 2022 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Insulin Pumps Quantitative research analysis
Global Insulin Pumps Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

Top performing companies in the Global Insulin Pumps market are Medtronic (Ireland), Tandem Diabetes Care (United States), Insulet Corporation (United States), F. Hoffmann-La Roche Ltd (Switzerland), Animas Corporation (United States), SOOIL Development (South Korea), New Genix (Spain), Debiotech (Denmark), Asante Solutions (United States) and Apex Medical (United States), to name a few.
"" is seen as one of major influencing trends for Insulin Pumps Market during projected period 2022-2028.
Pumps segment in Global market to hold robust market share owing to "".

Know More About Global Insulin Pumps Report?

Have a Query? Click Here

Other Related Reports

Zippers Comprehensive Study by Application (Garment, Luggage & Bags, Sporting Goods, Camping gear, Others), Category (Separable zipper, Non-Separable Zipper, Exposed Zipper, Waterproof Zipper), Mater...
$ 3800
Industrial Computer Comprehensive Study by End-User Vertical (Process Industries (Chemical, Energy and Power, Food and Beverages, Oil and Gas, Pharmaceutical, Other Process industries), Discrete Indu...
$ 3750
Corneal Implants Comprehensive Study by Type (Human Donor, Artificial Cornea), Application (Hospitals, Eye Clinics, Ambulatory Surgical Centers, Diagnostic Laboratories, Research & Academic Laborator...
$ 3750
Telecom Towers Comprehensive Study by Type (Lattice Tower, Guyed Tower, Monopole Tower, Camouflage Towers, Mobile (Vehicle Mounted) Tower), Ownership (Operator-Owned, JV, Private-Owned), Installtion ...
$ 3450
Mast Tower Comprehensive Study by Application (Antennas, Lighting Equipment, Surveillance Cameras, Wind Turbines, Weather Instruments, Power Lines, Others), Material Type (Aluminium, Steel, Stainle...
$ 3750
Microsegmentation Technology Comprehensive Study by By Component (Software, Services), By End User (Healthcare, IT Telecom, Government Defense, BFSI, Others), By Enterprise Size (Small, Medium, Large...
$ 3800